CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”) received the Drug Clinical …

CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity Read More

Jabaly Law Strengthens Commercial Litigation Services to Support Virginia Businesses Facing Contract Disputes and Complex Legal Conflicts

Expanding litigation capabilities to address commercial disputes affecting small and mid-sized Virginia businesses. Alexandria, Virginia, 5th March 2026, ZEX PR WIRE — Jabaly Law has strengthened its commercial litigation services to address the evolving …

Jabaly Law Strengthens Commercial Litigation Services to Support Virginia Businesses Facing Contract Disputes and Complex Legal Conflicts Read More